OREANDA-NEWS. PSI CRO, a full-service contract research organization, announced today the appointment of Sabine Debuschewitz as Country Manager for PSI Germany. Mrs. Debuschewitz is based out of the company's office in Munich.

Mrs. Debuschewitz brings to PSI medical experience and experience in clinical research with pharma, biotech and CROs spanning over 15 years. During her career, Mrs. Debuschewitz has had a first-hand exposure to the practicalities of clinical operations, global project management and medical monitoring. She is very familiar with the investigator community in Germany and beyond across multiple therapeutic areas. Her therapeutic background included work in the following areas: Oncology, Virology, Cardiology, Gastroenterology, Immunology and Vaccines.

Over the years PSI's Munich office has become an important European operational hub. It houses Heads of global PSI functions, such as Medical Affairs, Clinical Operations, Training & Resourcing, and offers services that include Feasibility, Project Management and Monitoring, PVG, Regulatory and Legal support. PSI is very active setting up clinical trials in Germany in a variety of therapeutic areas, such as Oncology, Haematology, Infectious Diseases, CNS, Urology, Cardiology, and other areas, including PSI's specialization in Rare Diseases and Paediatric studies. On-time and on-budget project delivery is the focus of the German operation, much like the rest of the global PSI.